Hyperbaric Oxygen Therapy in Diabetic Foot

NCT06502808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-07-16

No results posted yet for this study

Summary

This study seeks to assess changes in genes that are related to inflammation and oxidative stress in patients with type 2 Diabetes with diabetic foot treated with hyperbaric chamber

Conditions

  • Diabetic Foot Ulcer Neuropathic

Interventions

OTHER

Hyperbaric oxygen therapy

Series of 30 HBOT sessions of 60 minutes at 2 ATA in the hyperbaric chamber for five consecutive days per week.

Sponsors & Collaborators

  • National Polytechnic Institute, Mexico

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-01-15
Completion
2020-07-15

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06502808 on ClinicalTrials.gov